CET - Theranexus, an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces the publication of its letter to shareholders. To ...

Silver Spring, MD, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) ("BTCS" or the "Company"), a leader in blockchain ...

Daily eNewsletter provides latest news and information for architects and designers, including original 'featured articles,' ...